Pharmaceutical - Healthcare
The pharmaceutical sector is confronted today with multiple challenges:
- increasing development costs of new molecules
- pressure from government authorities on prices, de-reimbursement of certain products judged insufficient by the French MSR (improvement of medical service rendered)
- increased market share of generics
- challenge of new actors and the necessity to clarify ethical and OTC distribution strategies
- concentrations, diversifications and restructurings in the market
- questioning of the "Blockbuster" model
PMP's added value in this context is focused on three themes:
R&D management
- diagnostic of R&D activities
- evaluation methodology of molecule portfolios
- management support of complex projects
- Drug Discovery performance
- Collaboration strategy
strategic plans
- observation of French and international health policy
- product/market positioning
- deployment of new partnerships and services (business developments)
- "Make or Buy" choice and alignment of commercial and industrial operations
operational and financial performance
- elaboration of cost reduction and working capital improvement plans
- performance improvement management
- efficiency of sales networks and multi-brand vendors
- optimisation of industrial processes and Supply Chain
- rationalisation of the purchasing portfolio
- implementation of management control processes and reporting at the operational and financial levels
PMP's culture of "pragmatism and results" permits the development of real partnerships with our clients: "Big Pharma", independent French laboratories, Biotechs, veterinary laboratories, cosmetic industry…
Print